© 2026 nimisham.in
A once-weekly insulin injection is an exciting development in diabetes care, but is it automatically better for everyone? That s the question we asked experts as Danish drugmaker Novo Nordisk (NOVOb.CO) recently launched its weekly basal insulin injection, Awi
Novo Nordisk India has launched the world's first once-weekly basal insulin, Awiqli, for adults with type 1 and type 2 diabetes. It reduces the injection burden from seven injections a week to just one, bringing greater convenience to diabetes management
Novo Nordisk has launched Awiqli, a new weekly basal insulin injection, in India. This innovative drug offers a once-weekly alternative to daily injections for diabetes patients